Serum interleukin-6 and C-reactive protein are markedly elevated in acute decompensated heart failure patients with left ventricular systolic dysfunction. 2010

Mika Matsumoto, and Takeshi Tsujino, and Masaaki Lee-Kawabata, and Yoshiro Naito, and Tsuyoshi Sakoda, and Mitsumasa Ohyanagi, and Tohru Masuyama
Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.

Cytokines play important roles in heart failure (HF). We examined whether cytokine levels are different in acute decompensated heart failure (ADHF) patients between with left ventricular systolic dysfunction (LVSDF) and with preserved LV ejection function (PLVEF). We studied 81 HF patients who were admitted to our hospital with acute decompensation. They were divided into two groups: LVSDF (LVEF)<45% and PLVEF (LVEF45%). Serum interleukin-6 (IL-6), highly sensitive C-reactive protein (hsCRP), tumor necrosis factor alpha (TNF-alpha), and IL-18 and plasma brain natriuretic peptide (BNP) were measured on admission and at discharge. On admission, IL-6 and hsCRP were higher in LVSDF than in PLVEF. IL-6 and hsCRP decreased after treatment in LVSDF, but not in PLVEF, while plasma BNP levels decreased in both HF with treatment. There was no difference in TNF-alpha or in IL-18 level between LVSDF and PLVEF, and they did not change after treatment in either group. In conclusion, cytokine profiles were different in ADHF between those with LVSDF and PLVEF. Activation of IL-6-hsCRP pathway may play a specific role in ADHF with LVSDF.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

Mika Matsumoto, and Takeshi Tsujino, and Masaaki Lee-Kawabata, and Yoshiro Naito, and Tsuyoshi Sakoda, and Mitsumasa Ohyanagi, and Tohru Masuyama
March 2001, American heart journal,
Mika Matsumoto, and Takeshi Tsujino, and Masaaki Lee-Kawabata, and Yoshiro Naito, and Tsuyoshi Sakoda, and Mitsumasa Ohyanagi, and Tohru Masuyama
October 2013, International journal of cardiology,
Mika Matsumoto, and Takeshi Tsujino, and Masaaki Lee-Kawabata, and Yoshiro Naito, and Tsuyoshi Sakoda, and Mitsumasa Ohyanagi, and Tohru Masuyama
February 2006, Journal of cardiac failure,
Mika Matsumoto, and Takeshi Tsujino, and Masaaki Lee-Kawabata, and Yoshiro Naito, and Tsuyoshi Sakoda, and Mitsumasa Ohyanagi, and Tohru Masuyama
February 2008, The American journal of cardiology,
Mika Matsumoto, and Takeshi Tsujino, and Masaaki Lee-Kawabata, and Yoshiro Naito, and Tsuyoshi Sakoda, and Mitsumasa Ohyanagi, and Tohru Masuyama
June 2011, International journal of cardiology,
Mika Matsumoto, and Takeshi Tsujino, and Masaaki Lee-Kawabata, and Yoshiro Naito, and Tsuyoshi Sakoda, and Mitsumasa Ohyanagi, and Tohru Masuyama
June 1994, Clinical practice guideline. Quick reference guide for clinicians,
Mika Matsumoto, and Takeshi Tsujino, and Masaaki Lee-Kawabata, and Yoshiro Naito, and Tsuyoshi Sakoda, and Mitsumasa Ohyanagi, and Tohru Masuyama
January 2022, Caspian journal of internal medicine,
Mika Matsumoto, and Takeshi Tsujino, and Masaaki Lee-Kawabata, and Yoshiro Naito, and Tsuyoshi Sakoda, and Mitsumasa Ohyanagi, and Tohru Masuyama
January 2013, Congestive heart failure (Greenwich, Conn.),
Mika Matsumoto, and Takeshi Tsujino, and Masaaki Lee-Kawabata, and Yoshiro Naito, and Tsuyoshi Sakoda, and Mitsumasa Ohyanagi, and Tohru Masuyama
April 2015, International journal of cardiology,
Mika Matsumoto, and Takeshi Tsujino, and Masaaki Lee-Kawabata, and Yoshiro Naito, and Tsuyoshi Sakoda, and Mitsumasa Ohyanagi, and Tohru Masuyama
April 2018, The Canadian journal of cardiology,
Copied contents to your clipboard!